Skip to main content

Search

Reset all filters
131 Result(s)
Sort by

Rare Diseases: Rare but not alone

Rare Diseases: Rare but not alone

We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
Obesity osteoarthritis in pets a blind spot

Obesity osteoarthritis in pets a blind spot

Body weight is just one indicator among many when it comes to a pet’s health status, but there are some diseases associated with it. Learn more here.
Expectations towards our business partners

Expectations towards our business partners

Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.
Patient Documentary

Patient Documentary

People with type 2 diabetes are two to four times more likely to develop heart disease compared with people without diabetes
COVID-19 Volunteering in the U.S.

COVID-19 Volunteering in the U.S.

BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Innovation Through Cooperation

Innovation Through Cooperation

Exchange of information between pharmaceutical manufacturers and healthcare professionals is essential for patients. Click here to learn more.
Pet industry trends Millennials

Pet industry trends Millennials

Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
COVID-19 Q&A for Patients

COVID-19 Q&A for Patients

Corona and COVID-19 can lead to many questions. We want to answer a few of them, provide some general information and give some recommendations.
The Core of our Leitbild

The Core of our Leitbild

Click here to find out about the core of our leitbild. Here you can find out information about who we are and what we strive for at Boehringer Ingelheim.
Our Health and Safety initiative - BE SAFE

Our Health and Safety initiative - BE SAFE

We strive to keep our employees in good health, supporting their well-being across all working environments. Learn about our BE SAFE initiative.
COVID-19 Q&A for people with diabetes

COVID-19 Q&A for people with diabetes

Here you can find a summary of COVID-19 advice for patients with diabetes. Click here to read the questions and answers to find out more information.
COVID-19 Supply Chain and Production

COVID-19 Supply Chain and Production

Supplying patients and customers with their medicines is our highest priority. Learn about COVID-19's impact on our supply chain and production here.
Our Approach

Our Approach

As a family-owned company, we are driven by the ambition to serve humankind by improving human and animal health. Find out more about our approach here.
The Supplier Code of Conduct

The Supplier Code of Conduct

Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
Introducing Karl and Klara Kidney

Introducing Karl and Klara Kidney

Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways. Click here to find out more.
Trust Through Transparency

Trust Through Transparency

Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
Bringing Precision to Psychiatry

Bringing Precision to Psychiatry

Dr Hugh Marston and Dr Vikas Mohan Sharma discuss how precision psychiatry can enable people living with mental health conditions to thrive. Learn more.